PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dr Harriet Kildahl joins PeroCycle as Technical Director

2025-10-21
(Press-News.org) University of Birmingham spin-out PeroCycle has announced the appointment of Dr Harriet Kildahl, who co-invented the company’s core technology, as Technical Director. 

Dr Kildahl, who devised the closed loop carbon recycling system technology with Professor Yulong Ding at the University of Birmingham, U.K., joins the PeroCycle team after a three-year stint in Environmental, Social, and Governance (ESG) consulting.

Her appointment forms a powerful partnership with PeroCycle CEO Grant Budge, who has led the development and commercialisation of CCS (Carbon Capture and Storage) and CCU (Carbon Capture and Utilisation) technologies for over a decade.

The company is currently raising £4.5 million for a development plan that includes the design and implementation of a pilot plant to demonstrate the technology’s performance and scalability, and is targeting the early completion of £1.5 million.

Dr Kildahl was instrumental in developing the process that converts CO₂ emissions from steel mills into usable carbon monoxide (CO), a feedstock that can replace coke in furnaces, enabling a closed carbon loop for heavy industry.

By turning CO₂ into a valuable resource, and directly at source, PeroCycle’s closed carbon loop technology offers a pragmatic, profitable route to net-zero manufacturing that could redefine how industries like steel, cement, and chemicals think about emissions.

Dr Kildahl and Grant Budge will lead PeroCycle’s mission to transform the performance and economics of industrial decarbonisation pathways.   

Grant Budge said: “Harriet brings not just technical excellence, but a visionary understanding of how carbon utilisation can reshape industrial economics. Together, we’re building a pathway that doesn’t just capture carbon, it keeps it in the loop.” 

Dr Kildahl said: “It’s incredibly exciting to return to the technology I helped develop and see it move towards real-world deployment. Joining PeroCycle is an opportunity to help shape the vision Professor Ding and I first imagined — and to see it come to life at industrial scale.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Exercise counteracts junk food's depression-like effects through gut-brain metabolic signaling

2025-10-21
CORK, IRELAND, 21 October 2025 -- Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise counteracts the negative behavioral effects of consuming a Western-style cafeteria diet. Published today in the peer-reviewed journal Brain Medicine, this research demonstrates that voluntary running exercise can mitigate depression-like behaviors induced by high-fat, high-sugar diets associated with both circulating hormones and gut-derived metabolites. The findings provide crucial insights into how lifestyle ...

Genetic link discovered between childhood intelligence and parental longevity

2025-10-21
EDINBURGH, Scotland, UNITED KINGDOM, 7 October 2025 -- Researchers led by Dr. W. David Hill at the University of Edinburgh have identified a significant genetic correlation between childhood cognitive function and longevity, providing the first molecular genetic evidence that intelligence measured in youth shares genetic factors with lifespan. Published today in the peer-reviewed journal Genomic Psychiatry, this Brevia represents a crucial advance in understanding why more intelligent children tend to ...

Psychedelics reshape time perception offering new therapeutic pathways

2025-10-21
CHANGCHUN, CHINA, 21 October 2025 -- A perspective article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examine how psychedelic substances profoundly reshape our perception of time, offering unprecedented insights into consciousness and potential therapeutic applications. The analysis synthesizes existing research on temporal distortions induced by substances including psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT), revealing how these compounds provide ...

Genetic inflammation markers reveal distinct depression subtypes affecting treatment response

2025-10-21
ENNA, ITALY, 21 October 2025 -- Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond to antidepressant medications, according to new peer-reviewed research published today in Genomic Psychiatry. The findings suggest that inherited predisposition to inflammation may help explain why certain patients experience particular symptom patterns and respond differently to standard treatments, potentially advancing efforts toward more personalized approaches in mental health care. Novel Genetic Architecture Uncovered The research team ...

Understanding how menopause symptoms can complicate treatment of traumatic brain injuries

2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Despite growing recognition of sex differences in traumatic brain injury (TBI) outcomes, the interaction between hormone transitions–particularly menopause–and brain injury remains significantly underexplored in both research and clinical care. A new study suggests a greater focus on hormone changes when diagnosing and treating TBIs in menopausal women. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25. The menopause transition ...

Digestive issues more common during perimenopause and menopause

2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Digestive health issues are highly prevalent among perimenopausal and menopausal women, with many reporting the onset or exacerbation of symptoms during this life stage. Despite symptom burden, formal diagnoses and effective treatment remain limited. That’s the conclusion of a new study focused on gut health during the menopause transition. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25. The hormone changes experienced during perimenopause and menopause ...

Oral or transdermal hormone therapy? The mental health risks are not the same

2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Hormone therapy–oral and transdermal–remains the most effective treatment for such bothersome menopause symptoms as hot flashes and is generally considered safe for most patients. A new study shows that risk profiles are different based on how the hormones are administered. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25. When it comes to hormone therapy, there is not a consistently preferred route of administration. ...

When women initiate estrogen therapy matters

2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone therapy has proven valuable in managing bothersome menopause symptoms. A new study suggests that when a woman starts taking hormones makes a major difference in longer term health outcomes. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25. A large percentage of women will experience some type of menopause symptoms, with the most common symptom ...

Risk of eye disease increases during menopause transition

2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal women exhibit a higher prevalence of dry eye disease than perimenopausal women. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25. Dry eye disease is a relatively common disease characterized by eyes not providing enough tears or ...

Life in the fast (and slow) lanes for salmon

2025-10-21
Kyoto, Japan -- Life-history variation is fundamental to the long-term persistence of populations and species because it ensures their ability to adapt to changing environments. Many important studies have focused on life-history variation between habitats, but the variation maintained within a habitat has often been overlooked. Unravelling this puzzle at the landscape level is critical for understanding the spatial scales at which adaption and population persistence operate in nature. This motivated a team of researchers at Kyoto University to investigate life-history variation in masu salmon. "We wanted to understand how the variation in life-history is partitioned within and ...

LAST 30 PRESS RELEASES:

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

[Press-News.org] Dr Harriet Kildahl joins PeroCycle as Technical Director